Patents by Inventor J. Kevin Steele

J. Kevin Steele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6204003
    Abstract: The claimed invention is a method for determining whether a mammal is infected with Haemobartonella felis or for inducing an immune response against Haemobartonella felis using a polypeptide expressed by Mycoplasma. Preferably, the polypeptide is expressed by Mycoplasma gallisepticum. In a preferred embodiment the polypeptide is the pMGA protein expressed by the strain of Mycoplasma gallisepticum having ATCC deposit number 19610.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: March 20, 2001
    Assignee: Synbiotics Corporation
    Inventors: J. Kevin Steele, David L. Telford, John A. Cutting
  • Patent number: 4900547
    Abstract: A general enhancement of the immune system of an animal can be obtained by administration of a T-cell suppressor factor which is idiotypic with regard to any specific antigen when such administration is made in the presence of an effective amount of adjuvant.
    Type: Grant
    Filed: October 23, 1987
    Date of Patent: February 13, 1990
    Assignee: University of British Columbia
    Inventors: Julia G. Levy, J. Kevin Steele, Anthea T. Stammers
  • Patent number: 4898730
    Abstract: Factors secreted in the suppressor cascade are effective in contravening the suppression of the immune system in response to a particular antigen when properly administred. TsF2 factors may administered prior to or contemporaneously with the antigen; TsF1 factors, in order to exhibit this desired effect, must be administered prior to administration of antigen.
    Type: Grant
    Filed: March 13, 1987
    Date of Patent: February 6, 1990
    Assignee: The University of British Columbia
    Inventors: Julia G. Levy, J. Kevin Steele, Anthea T. Stammers